GLPwatch
Papers (10389)
Page 141 of 174, ranked by citation count.
- The short-term cost-effectiveness of once-weekly semaglutide versus once-weekly dulaglutide for the treatment of type 2 diabetes mellitus in Colombian adults.
- Time-Efficacy Relationship of Semaglutide in the Treatment of Type 2 Diabetes Mellitus: A Model-Based Meta-Analysis.
- [Impact on weight loss and body composition of a food education intervention associated with Liraglutide treatment to address obesity].
- Real-World Effectiveness of Finerenone Added to SGLT2 Inhibitor and GLP-1 Receptor Agonist Therapy in Individuals with Type 2 Diabetes and Chronic Kidney Disease.
- A comment on tirzepatide versus glucagon-like peptide-1 receptor agonists and heart rate with regard to 'Impact of a dual glucose-dependent insulinotropic peptide/glucagon-like peptide-1 receptor agonist tirzepatide on heart rate among patients with type 2 diabetes: A systematic review and pairwise and network meta-analysis'.
- Liraglutide as a novel therapeutic for overweight in canines: A clinical study.
- AISF practice guidance on pharmacological treatment of metabolic-dysfunction associated steatotic liver disease and steatohepatitis (MASLD/MASH): A 2026 Update.
- Effects of Liraglutide on Mitigation of Hearing Loss After Repeated Blast Exposures: A Summary of Studies in Animal Model of Chinchilla.
- [Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk factors and the cardiovascular system].
- GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS FOR TYPE 2 DIABETES: A COMPREHENSIVE REVIEW OF HOW TO WEIGH THE OPTIONS, SELECT THE RIGHT PATIENTS, AND MAXIMIZE BENEFITS.
- Treatment of obesity in spinal cord injury with tirzepatide: a case report.
- Effective weight loss after treatment with a glucagon-like peptide-1 receptor agonist in a morbidly obese and diabetic patient before bariatric surgery: a case report.
- [Influences of exendin-4 on the secretion function of islet beta cells from rats in the early stage of severe scald].
- A Retrospective Analysis of Liraglutide (GLP-1 Agonist) Use in a Chinchilla (<i>Chinchilla lanigera</i>) Model of Auditory Blast Injury.
- Liraglutide Attenuates Disease Severity in Experimental Autoimmune Encephalomyelitis by Modulating Splenic T Helper Cell Subsets.
- Lean Mass Changes With Incretin Therapy Versus Lifestyle Intervention: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
- Comparative effectiveness of tirzepatide and semaglutide for obesity management in US clinical practice: a 6-month retrospective cohort study.
- Characterization of 0839 - A tool compound for pre-clinical mode-of-action studies of amylin analogues such as cagrilintide.
- Reply: <sup>68</sup>Ga NODAGA-Exendin-4 PET Scanning for Focal Congenital Hyperinsulinism: Need for Replication.
- GLP-1 receptor agonist exendin-4 suppresses food intake by inhibiting hindbrain orexigenic NPY neurons.
- Bolus Injection of Liraglutide Raises Plasma Glucose in Normal Rats by Activating Glucagon-like Peptide 1 Receptor in the Brain.
- How to reset metabolic setpoint in obesity management.
- Semaglutide Initiation in a Type 2 Diabetes Mellitus, Post-Liver Transplant Patient.
- Med14 phosphorylation shapes genomic response to GLP-1 agonists.
- Tirzepatide: A Double Agonist for Various People Living with Type 2 Diabetes.
- Can a monthly exenatide extended release regimen provide a therapeutic and cost benefit?
- Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Obese Patients Without Diabetes: A Systematic Review and Meta-Analysis.
- Biological activity studies of the novel glucagon-like peptide-1 derivative HJ07.
- Early glucagon-like peptide-1 receptor agonist use after myocardial infarction in patients with type 2 diabetes.
- Role of Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in Management of Cardiovascular-Kidney-Metabolic (CKM) Conditions.
- Liraglutide preserves endothelial function in ophthalmic arteries of septic mice via prevention of oxidative stress.
- Extended-release exenatide (Bydureon) for type 2 diabetes.
- Comparison of PET/CT using <sup>68</sup>Ga-NOTA-Exendin-4 with <sup>68</sup>Ga-DOTATATE, <sup>18</sup>F-FDG, and conventional imaging in the localization of insulinomas.
- Trends and projections of overweight and obesity among midlife women in the United States, 1990-2050: A sub‑study of the Global Burden of Disease 2021.
- Semaglutide versus tirzepatide for people with type 2 diabetes: cost of glycemic control in Austria, the Netherlands, Lithuania, and the United Arab Emirates.
- Weight Loss Patterns and Clinical Outcomes of GLP1 Receptor Agonists in Breast Cancer Survivors.
- [Obesity treatment: will pharmacotherapies replace metabolic surgery in the future?]
- A potential association between tirzepatide and hypercalcemia in the setting of chronic hydrochlorothiazide use.
- The construction of long-acting exendin-4 analog and its hypoglycemic effect in diabetic mice.
- Apitegromab for lean mass preservation during tirzepatide-induced weight loss: a randomized, double-blind, placebo-controlled phase 2 trial.
- Liraglutide (Saxenda) for weight loss.
- Clinical experience with liraglutide.
- The Interplay Between GLP-1-Based Therapies, the Gut Microbiome, and MASLD/MASH in Type 2 Diabetes Mellitus: A Narrative Review.
- Efficacy of tirzepatide versus semaglutide in achieving therapeutic targets in type 2 diabetes: a post hoc analysis of the SURPASS-2 Trial.
- Effects of new hypoglycemic drugs on patients with heart failure: a systematic review and network meta-analysis.
- Effect of semaglutide on arrhythmic, major cardiovascular, and microvascular outcomes in patients with type 2 diabetes: a systematic review and meta-analysis.
- Effects of Dulaglutide on Ectopic Fat Deposition in Chronic Kidney Disease (CKD): A Pilot and Feasibility Study (GLIMP).
- Treatment of obesity-related HFpEF: a STEP closer to the SUMMIT.
- Exenatide's effect in reducing weight and glycosylated hemoglobin level in an Arab population with type 2 diabetes.
- [Successful treatment of KCNJ11 neonatal diabetes without insulin].
- [Pharmacotherapy for obesity].
- Efficacy and Safety of Empagliflozine and Semaglutide (Once Weekly) in T2DM Patients in Shtip.
- Incretin Analogs for Weight Management in Adults Without Diabetes.
- Implications of GLP-1 Agonists on Office-Based Sedation and General Anesthesia for Dentistry.
- Real-World Safety Concerns of Tirzepatide: A Retrospective Analysis of FAERS Data (2022-2025).
- Tirzepatide reverses hypothalamic inflammation, cellular stress, and neuropeptide imbalance in metabolic-menopausal dysfunction.
- Rate of Age-Related Macular Degeneration in Patients Prescribed Glucagon-Like Peptide-1 Receptor Agonists or Other Weight Loss Therapies.
- Tirzepatide and Cardiovascular Outcomes in Patients With Ventricular Tachycardia and Systolic Heart Failure.
- Semaglutide and tirzepatide in prediabetes: Evidence for diabetes prevention and cardiovascular protection.
- Clinical Manifestations of Semaglutide Overdose: A Case Study.